Lifecore Biomedical, Inc. LFCR Reportable Segment — Income tax expense (benefit)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s reportable segment — income tax expense (benefit).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s reportable segment — income tax expense (benefit)?
- Lifecore Biomedical, Inc. (LFCR) reported reportable segment — income tax expense (benefit) of $43K in Q1 2026.
- What does reportable segment — income tax expense (benefit) mean?
- This metric reflects the total income tax provision or benefit allocated to the specific business segment based on its pre-tax earnings and applicable jurisdictional tax rates. It represents the portion of the segment's financial results that is diverted to tax authorities or recovered through tax credits. Analyzing this figure is essential for understanding the segment's effective tax burden and its contribution to the company's overall tax profile.